<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20100524004010N25</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-07-24</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences, National Nutrition and Food Technology Research</primary_sponsor>
      <public_title>The effect of Nigella sativa on Non-Alcoholic Fatty Liver Disease(NAFLD)</public_title>
      <acronym></acronym>
      <scientific_title>The effect of Nigella sativa consumption on lipid profile, liver enzymes, inflammatory factors and hepatic steatosis in patients with Non-Alcoholic Fatty Liver Disease(NAFLD)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-02-28</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/4197</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Patients will be randomly assigned  to receive Nigella sativa or placebo, Blinding description: For randomization process,  simple randomization method is used by random number table. At the beginning of the study, in order to blind the  researchers to group assignment, the cans containing the  capsules are coded by another person instead of the researcher to A and B as intervention and control groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Non alcoholic fatty liver disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: 2 gr per day nigella sativa daily for 3 months. Intervention 2: Placebo group: 2 gr per day starch daily for 3 months.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is We have not yet decided for it.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Azita Hekmatdoost</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 7, West Arghavan Ave., Farahzadi Blvd., Hafezi Ave</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>123456</zip>
        <telephone>+98 21 2235 7483</telephone>
        <email>a_HEKMAT2000@YAHOO.COM</email>
        <affiliation>Shahid Beheshti University of Medical Sciences, National Nutrition and Food Technology Research</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Azita Hekmatdoost</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>West arghavan, Sanaat square, Farahzadi boulvard, Shahrake gharb</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>123456</zip>
        <telephone>+98 21 2235 7483</telephone>
        <email>a_hekmat2000@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences, National Nutrition and Food Technology Research</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>18 years old  and older
Evidence of nonalcoholic steatohepatitis in Fibroscan  (Controlled Attenuation Parameter (CAP) score&gt; 263)
absence of pregnancy and lactation</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Unwillingness to continue study for any reason.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>(K75.8)</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other specified inflammatory liver diseases</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: 2 gr per day nigella sativa daily for 3 months</i_keyword>
      <i_keyword>Placebo group: 2 gr per day starch daily for 3 months</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>HOMA. Timepoint: Begining and end of the study. Method of measurement: Calculation.</prim_outcome>
      <prim_outcome>TNF-α. Timepoint: Begining and end of the study. Method of measurement: Elisa.</prim_outcome>
      <prim_outcome>IL-6. Timepoint: Begining and end of the study. Method of measurement: Elisa.</prim_outcome>
      <prim_outcome>Hepatic Steatosis. Timepoint: Begining and end of the study. Method of measurement: Ultrasound.</prim_outcome>
      <prim_outcome>LDL-C. Timepoint: Begining and end of the study. Method of measurement: Enzymatic methods using a kit.</prim_outcome>
      <prim_outcome>HDL-C. Timepoint: Begining and end of the study. Method of measurement: Enzymatic methods using  a kit.</prim_outcome>
      <prim_outcome>TG. Timepoint: Begining and end of the study. Method of measurement: Enzymatic methods using a kit.</prim_outcome>
      <prim_outcome>Total Cholesterol. Timepoint: Begining and end of the study. Method of measurement: Enzymatic methods using  a kit.</prim_outcome>
      <prim_outcome>Serum Insulin. Timepoint: Begining and end of the study. Method of measurement: Radioimmunoassay.</prim_outcome>
      <prim_outcome>FBS. Timepoint: Begining and end of the study. Method of measurement: Enzymatic methods using a kits.</prim_outcome>
      <prim_outcome>AST. Timepoint: Begining and end of the study. Method of measurement: Enzymatic methods using  a kits.</prim_outcome>
      <prim_outcome>ALT. Timepoint: Begining and end of the study. Method of measurement: Enzymatic methods using  a kit.</prim_outcome>
      <prim_outcome>Total energy intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.</prim_outcome>
      <prim_outcome>Carbohydrate intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.</prim_outcome>
      <prim_outcome>Protein intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.</prim_outcome>
      <prim_outcome>Total fat intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.</prim_outcome>
      <prim_outcome>SFA  intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.</prim_outcome>
      <prim_outcome>PUFA intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.</prim_outcome>
      <prim_outcome>MUFA intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.</prim_outcome>
      <prim_outcome>Fiber intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Total energy intake. Timepoint: Begining and end of the study. Method of measurement: Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences, National Nutrition and Food Technology Research</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-02-19</approval_date>
        <contact_name>National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sci</contact_name>
        <contact_address>West Arghavan, Sanaat Square, Farahzadi Boulvard, Shahrake Gharb Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
